France vs United Arab Emirates: Immunization, Hib3
France
96.0%
in 2024
United Arab Emirates
96.0%
in 2024
France rank
46th
United Arab Emirates rank
46th
Immunization, Hib3 over time
- France
- United Arab Emirates
How they compare
France currently reports 96.0% against 96.0% in United Arab Emirates, a difference of 0.0%.
The two have swapped places 4 times across 26 shared years of data; in 1999 it was United Arab Emirates ahead.
France ranks 46th and United Arab Emirates ranks 46th of 191 countries.
Across the 4 decades both report, France averaged higher in 1 and United Arab Emirates in 3.
Head to head by decade
| Decade | France | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 85.0% | 94.0% | 9.0% | United Arab Emirates |
| 2000s | 92.8% | 92.9% | 0.1% | United Arab Emirates |
| 2010s | 94.9% | 97.6% | 2.7% | United Arab Emirates |
| 2020s | 96.0% | 94.8% | 1.2% | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, France or United Arab Emirates?
- France, at 96.0% against 96.0% in United Arab Emirates as of 2024.
- What is the difference in immunization, hib3 between France and United Arab Emirates?
- 0.0%, with France ahead.
- How many years of comparable data are there for France and United Arab Emirates?
- 26 years are reported by both, from 1999 to 2024.
- How do France and United Arab Emirates rank globally for immunization, hib3?
- France ranks 46th and United Arab Emirates ranks 46th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.